Online CME activity
Access activity > (Medscape requires a one-time free registration to access the activity)
Expiration date Nov 30, 2013
Description
This 45-minute case-based activity explores updated post-transplant screening recommendations for autologous and allogeneic hematopoietic cell transplant (HCT) recipients, including: risk factors associated with exposures and late effects, guidelines for head-to-toe assessment and screening and vaccination schedules.
Target Audience
This activity is intended for Hematologists, Oncologists, Internists, Family Practitioners, and healthcare practitioners who care for patients following HCT.
Faculty
Navneet Majhail, M.D., M.S.
Medical Director, Health Services Research, National Marrow Donor Program
Adjunct Associate Professor of Medicine, University of Minnesota
Minneapolis, MN
Linda Burns, M.D.
Professor of Medicine, Department of Hematology Oncology and Transplantation, University of Minnesota
Medical Director of the Inpatient Adult Bone Marrow Transplant Unit at Fairview-University Medical Center
Minneapolis, MN
Learning Objectives
- Identify pre-, peri- and post-transplant exposures and risk factors associated with late complications of transplant.
- Apply appropriate screening and prevention testing for complications when caring for HCT survivors and determine treatment based on individual exposures and risk factors including those that occur in special populations.
- Assess the communication needs of a multidisciplinary team including transplant centers, primary care physicians and other health care providers to provide follow-up care of transplant survivors.
Accompanying clinical resources
Accreditation and certification
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape Education Oncology and the National Marrow Donor Program® (NMDP). Medscape is accredited by the ACCME to provide continuing medical education for physicians.
Medscape designates this enduring material for a maximum of 0.75 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Questions
If you have any questions regarding this activity, call Renee Ryan at (800) 526-7809 ext. 8430, or e-mail rryan@nmdp.org.